SGMO icon

Sangamo Therapeutics

111 hedge funds and large institutions have $408M invested in Sangamo Therapeutics in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 9 closing their positions.

Holders
111
Holders Change
+12
Holders Change %
+12.12%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
22
Increased
40
Reduced
26
Closed
9
Calls
$82.4M
Puts
$5.11M
Net Calls
+$77.3M
Net Calls Change
+$19.7M
Name Market Value Shares Shares
Change
Shares
Change %
Ameriprise
101
Ameriprise
Minnesota
$37K 3,540
NCM
102
Nelson Capital Management
California
$31K 3,000
PCM
103
Prelude Capital Management
New York
$28K 2,700 -4,076 -60%
PSI
104
Pinnacle Summer Investments
Virginia
$16K 1,500
TRCT
105
Tower Research Capital (TRC)
New York
$16K 1,541 +1,259 +446%
BlackRock
106
BlackRock
New York
$14K 1,363
HI
107
Hudock Inc
Pennsylvania
$10K 1,000
Creative Planning
108
Creative Planning
Kansas
$4K 400 +400 New
LTFS
109
Ladenburg Thalmann Financial Services
Florida
$2K 200
LFR
110
Lehman Financial Resources
Pennsylvania
$2K 200
Manulife (Manufacturers Life Insurance)
111
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$434 41,358 -902 -2%
KIA
112
Kopp Investment Advisors
Minnesota
-320,700 Closed
PP
113
PDT Partners
New York
-89,647 Closed
OAM
114
Oxford Asset Management
United Kingdom
-79,432 Closed
Wellington Management Group
115
Wellington Management Group
Massachusetts
-67,800 Closed
Nomura Holdings
116
Nomura Holdings
Japan
-36,315 Closed
Group One Trading
117
Group One Trading
Illinois
-25,341 Closed
Renaissance Technologies
118
Renaissance Technologies
New York
-17,000 Closed
MWNA
119
Marshall Wace North America
New York
-11,701 Closed
CFA
120
Camarda Financial Advisors
Florida
-800 Closed
WAM
121
Wolverine Asset Management
Illinois
Bank of Montreal
122
Bank of Montreal
Ontario, Canada